SlideShare a Scribd company logo
1 of 47
TIC DISORDERS
Presenter: Dr. Sarah. N
Chair: Dr. Tinku Wilson
CONTENTS
• Definition
• History
• Epidemiology
• Etiopathogenesis
• Classification
• Clinical features
• Diagnostic Criteria
• Approach
• DD &Comorbid conditions
• Course and prognosis
• Management
INTRODUCTION
• Tics: rapid, non rhythmic, recurring, involuntary or semi
voluntary, sudden onset, motor movements or vocalizations.
• Complex, heterogenous, neurodevelopmental disorders.
HISTORY
• Itard (1825) : first clinical description of
Tourette syndrome on Marquise de
Dampierre.
• Georges Edouard Albert Brutus Gilles de la
Tourette (1885) : described in 9 patients,
coined term coprolalia
• Charcot : believed in Heriditary
degenerative disorder.
Gilles de la
Tourette
EPIDEMIOLOGY
Tic
disorder
overall
prevalence
6.5%
Typical age 3-8yrs
Avg age 6yrs
M>F by 3-4 times
Provisional Tic D/o (MC)
20% prevalence in school age
Persistent tic d/o
2-4% prevalence
Tourette disorder 0.77% prevalence
• 79% comorbid
Mental health/
Neurodevelopment
condition.
• 60-70% comorbid
ADHD
• 50% comorbid OCD.
ETIOPATHOGENESIS
• CSTC
• Androgen exposure
• High hypothalamic-
pituitary-adrenal
axis
• Prenatal and
perinatal insults:
• Hypoxia, ischaemia
• Forceps delivery
• Exposure to alcohol
• Caffiene, cigarettes
• Molecular
Mimicry
• Antineuronal
antibodies.
• PANDAS
• Inherited
Neurodevelop
mental
Disorder.
GENETIC
FACTORS
IMMUNOLOGY
NEUROPHYSIO
AND
NEUROCHEM
ENVIRONMEN
TAL
Genetic factors
• Twin studies: High concordance in MZ (50-90%)
• Multigene loci with environmental factors.
• Linkage study by TSAICG: linkage region on Chr 2p, duplication
of long arm Chr 7
• Balanced transloction Chr 6 and 8
• Candidate gene SLITRK1 on Chr 13Q31.1
• Functional mutation of HDC encoding l-histidine decarboxylase.
• Dopamine receptor gene, transporter gene, noradrenegic
genes, serotonergic genes.
Neuroanatomy
Neurophysiology and
Neurochemistry
• :
Dopaminergic abnormality
Excessive cortical/ nigrostriatal dopaminergic
activity.
Dopamine tonic-phasic model
Serotonergic abnormality
Decreased Serotonin in BG and CSF
Influence Dopamine release
Norepinephrine
Increase: Influence Dopamine surge
fMRI: Voluntary tic supression : activity in DLPFC, CN
SPECT :Abnormal Dopaminergic Neurotransmission.
Midbrain dopaminergic neurons.
MRS : Neurochemichal changes
• Loss of assymmetry of BG
• Volumetric changes in Striatum, thalamus, amygdala,
hippocampus
• PFC & CN volume changes: inversely related to tic
• Corpus callosal volume changes
• Cortical thinning: Frontal and Parietal lobes.
Neuroimaging
CLASSIFICATION
PRIMARY
Sporadic
a. Transient tic d/o
b. Chronic tic d/o
c. Adult onset tics
d. TS
Inherited
a. TS
SECONDARY
1. Inherited: Huntington,
Neuroacanthocytosis, TS, WD,
Duchene Mascular Dystrophy
2. Infections: CJD,
Neurosyphilis, Sydenham
3. Drugs:Antipsychotics,
Levodopa, Amphetamine,
Methylphenidate
4. Toxins: CO
5. Chromosomal Disorders: ASD
6. Developmental: Downs, XXY,
Fragile X
7. Others: Trauma, Stroke,
Neurodegenerative d/s
TICS
MOTOR
• Simple
• Clonic:eye blinking, shoulder
shrugging, head turning
• Dystonic: blepharospsm,
bruxism, torticollis, occcular
deviation, mouth opening.
• Tonic : tensed abdominal or
limb muscles.
• Complex: touching, jumping,
rotating, echopraxia,
copropraxia
VOCAL
• Simple: throat clearing,
coughing, sniffing,
blowing, barking
• Complex: palilalia,
echolalia, coprolalia
CLINICAL
FEATURES
• Occurs in bouts.
• Change in frequency, anatomical
site, number, complexity, severity.
• May persist during sleep
• Can be suppressed.
• Associated with sensory
phenomenon.
• Premonitary urges: uncomfortable sensation preceding tics, need to
itch, sneeze, restlessness…Mounting tension.
• 82-92% of adults and adolescent reports PU.
• warning sign : can be utilized in CBT.
• Execution of a tic till it feels good : “Just right phenomenon”
• Somatic hypersensitivity: deficit in sensorimotor gating in TS and
Schizophrenia.
• Prepulse inhibition: startle response to low intensity stimulus prevents
startle response to high intensity stimulus of same kind; impaired in TS.
Exacerbating and relieving factors.
Exacerbating
• Tic related conversation.
• Overt observation
• Stress
• Anxiety
• Public commenting
Relieving
• Relaxation
• Mental or Physical task
• Rewarding tic free
period.
PANDAS
• Paediatric Autoimmune
Neuropsychiatric Disorder
Associated with Stretococcus
• Gp A betahaemolytic streptococci.
• Molecular mimicry
• Multiple streptococcal infection in
preceding 12 months : high risk.
• Evaluation of Tic/ OCD for
pharyngitis/ Strep exposure; throat
culture, ASO, anti-DNAse B titres.
• Antibiotics
Diagnostic Features
• OCD & tic symptom
• Pre pubertal onset
• Episodic course
• Sudden explosive onset
• Exacerbation and
remissions
• Temporal relation with
GABHS infection.
Diagnostic Criteria
• DSM 5
Neurodevelopmental disorders
• Tourette Disorder:
Both multiple motor and vocal tics
>1 yr since first tic onset
Onset before 18yrs
• Persistent (Chronic) Motor or
Vocal Tic Disorder
Single or multiple motor or vocal
tic, not both.
• Provisional Tic disorder
Motor and/or vocal tics
<1 yr since onset.
• Other specified & Unspecified
Tic Disorders.
• ICD 10
Disorders of Childhood and
Adolesence
F95 Tic disorders
• F95.0 Transient Tic Disorder :
<12 months
• F95.1 Chronic Motor or Vocal Tic
Disorder.
• F 95.2 Combined vocal and
multiple motor tic disorder (de
la Tourette’s syndrome)
• Other tic disorders( F95.8) and
unspecified(F95.9)
ICD 11
• Chapter 8 : Diseases
of Nervous System
• Primary & Secondary
Adult onset tic disorder
• True Prevalance not known
• ~55% recurrence of childhood tic disorder
• Of New adult onset tics, 50% has precipitating factors.
• Often involve face, neck and shoulders.
• Inciting event: head injury, local infection, cocaine binge,
neuroleptic drugs.
• Many unaware, unnoticed tics in childhood and family
members.
• Comorbid OC symptoms.
Approach to Tic disorders.
1. History :
• Present illness: Onset, course, severity, pattern, burden on
emotional, social, family, academic function ,ability to supress,
premonitory urges, aggrevating/ allevating factors, comorbidities,
medications/ substances.
• Developmental history, medical history.
• All child cases should be screened for unusual movements/
vocalizations.
2. Physical examination( including neurology) Ht, Wt, dysmorphic
features, posture, gait, reflex.
• AIMS
• Videotaped interviews
• Investigations: to r/o infectious etiology, Huntington disease, Wilson
disease.
• Specific neurological finding : Neuroimaging, genetic workup, EEG.
Categorisation : types,
dominant one, associated
features, DDs
Sudden onset ,severe
tics, atypical tics, mental
status abnormalities :
organic process : detailed
investigation.
Rating Scales
Yales Global Tic Severity Scale (YGTSS): assess number, frequency,
complexity, intensity, interference of vocal and motor tics. (Clinician
rated)
Tic Symptom Self Report
Tourette Syndrome Diagnostic confidence index (TSDCI)
Shapiro TS Severity Scale
TS Symptom list(TSSL)
Motor tic, Obsession and compulsion, vocal tic evaluation survey
(MOVES)
Clinical Global Impression Scale
Differential Diagnosis
TICS
Abnormal
movements
Myoclonus
Tremors
Akathesia
Athetosis
Chorea
Dystonia
Stereotypy
Spasm
Ballismus
Dyskinesia
Obsessive
Compulsive
Disorder
Huntington Disease
Sydenham’s Chorea
Hallevorden-Spatz
Wilson disease
Neuroacanthocytos
is
Substance
induced
Neuroleptic
induced
Post traumatic
CO Poisoning
Developmental
and benign
movement
disorders
Comorbid conditions
OCD
Impulse control
Disorders : Self
Injurious behaviour,
Intermittent
explosive diorder
Learning
disorder
(22.7%)
Mood
disorder
ADHD
ADHD
AND
TICS
50-75% have
ADHD
10/-30% OF
ADHD have tics
Low frustration
tolerance, over
aggression, Self
injurious
behaviour
Poor treatment
adherence
Inability to
delay
gratification.
Academic
difficulty
Peer
rejection
Poor
outcome
OCD
AND
TICS
20-40 %
meet
criteria for
OCD
Differ in
subjective
experience
of
Cognition,
Anxiety
and
Sensory
phenomen
on.
90%
subthreshold
symptoms:
repetitive
counting,
touching,
symmetry.
Share similar
Neurobiology:
overlap of
symptoms.
More severe
tics,
depressive
anxiety
symptoms
Comorbid
Trichotillomania,
BDD,Social
Phobia
Course and Prognosis
6-7 yrs
• Motor tics
• Rostrocaudal progression
• 94.8% eye tics
8-9 yrs
• Vocal tics
• Simple to complex
11-12 yrs
• OC symptoms
•Waxing-waning course
•Improve mid adolesence to adulthood;
65%
•19.3% coprophenomenon.
Course of Tourette Syndrome
Prognostic
factors
Comorbidities
OCD and ADHD
Presence of
Copropheno
menon and
Severe tics
Poor Parent
child
interaction
Peer difficulties
and Traumatic
life events
Management
• Physical pain
• Impaired
social/academic/occupati
onal performance.
Indication
• Decrease symptoms
• Support adaptive
functioning and strength
• Enhance developmental
progress.
Treatment
goals
Psychoeducation
Parent-Teachers-Physician work as partners.
Discuss family’s concerns and questions.
Optimal school environment.
Continuing education and support: Tourette
Syndrome Association.
Behavioural Interventions
• First line treatment :
Cognitive
Behavioural
Intervention
• Habit Reversal
Training (HRT) forms
essence of
Comprehensive
Behavioural
Intervention for Tics
(CBIT)
• Exposure and
Response
Prevention.
Competing
response training
Relaxation
training
Awareness
training
Contingency
management
Social support and
relapse prevention
At Home
Argumentati
ve :123
technique
time out
Coprolalia:
more
acceptable
words
Reward
acceptable
behaviour
Address
Sibling
concerns.
Me time”
for
caretaker
Screen time;
sleep
hygiene.
Addressing
public
comments
Responsible
behaviour
After school
bursts:
Relaxation
techniques,
sport
activities
Be
consistent,
clear &
specific
At School
• Parent-Teacher communication
• Avoiding , Critical /Negetive comments
• Rewarding good behaviour: Token system; Good
behaviour Diary
• Proper seating arrangements; permission to leave
classroom.
• Breaking activities to small chunks; using visual cues
• Extra time at exam/ worksheet with minimum writing
requirement.
• Public performance :not compelling
• Address peer bullying
• Building Self esteem
Medications
• Individualised planning: Addressing Comorbidities (OCD,
ADHD, Mood disorders)
• Initial work up: Blood parameters; ECG;FLP
• Lowest dose; gradual titration
• Monotherapy
Indication
Moderate-severe tics/ interfering
all functional areas
Psychotherapeutic options
unavailable/ not beneficial
Antipsychotics
• FDA approved : Haloperidol, Pimozide.
• Typicals: MOA: Block postsynaptic D2 receptors in BG.
• A/E : EPS
• Haloperidol: Children :0.125-0.25 mg daily
Adults :0.5 mg/day
• Pimozide :Children 0.5-1 mg; adults 1 mg/day
QT prolongation (CCB)
• Atypicals: Risperidone (most effective), Olanzapine, Ziprasidone,
Aripiprazole.
• MOA: block D2 & 5HT2 receptors
• Risperidone :1-3 mg, started at 0.25-0.5mg
• Ziprasidone 20-80mg, started at 5-10 mg
• Aripiprazole : 2.5-15mg ; started at 1.25-2.5mg
A/E: wt gain(Olanzapine), QT prolongation (Ziprasidone), Akathesia, sedation
(Aripiprazole)
Alpha adrenergic agonists
• First line ; comorbid ADHD
Clonidine α2 agonist:
presynaptic
autoreceptors
at Locus
Ceruleus
Prepubertal:
0.025mg
Adult :0.05mg
By 0.025 mg
every 5-14 days
0.05mg
increments
upto 8 μg
/kg/day
Head ache, dry
mouth,
stomach ache,
sedation, mid
sleep
awakening,
irritability.
Guanfacine Postsynaptic
prefrontal α
adrenergic
receptors
Prepubertal
:0.25mg
Adult 0.5 mg
By 0.025 mg
every 5-14 days
0.05mg
increments upto
3 mg/day
Sedation, mid
sleep wakening,
constipation,
hypotension.
•Transdermal form, Long acting Oral form available
•Monitor : ECG, BP, PR
Others
• SSRI: Tics + OC
Fluoxetine : Adults 20-80 mg; Children : 10-20mg
• TCA : Clomipramine, Desipramine
• Benzodiazepines: Anxiolytic
• Stimulants : Tic+ ADHD :Methylphenidate (0.1-0.5mg/kg)
• Non stimulant: Atomexitine
• Naltrexone(Opoid antagonist) :Self injurious behaviour.
Others
• Surgical Interventions:
DBS, TMS
• DBS: Severe, treatment
resistant, Self injurious
tics/cervical tics
Regions stimulated:
Centromedian Nucleus of
Thalamus, Gp interna , Gp
externa, STN, ventral
striatum, NA.
Botulinum Toxin Inj : Onabotulinum
Toxin A
For vocal tics
Last 12-16 weeks
Hypophonia
CONCLUSION
• Tics are Neurodevelopmental Disorders with Multiple
Etiopathogenesis.
• Classified as Motor and Vocal, Categorized again on severity
basis.
• Clinical features; Premonitary Urges, Sensory phenomenon
distinguishing features.
• Most common comorbid conditions are ADHD and OCD.
• Approach and evaluation to arrive at a diagnosis.
• Most require only Psychoeducation. First line management:
Behavioural Interventions.
• Medication only in selected cases, Individualized approach.
REFERENCE
• 1. Kaplan and Sadock Comprehensive Text Book of Psychiatry 10th edition.
• 2.Practice parameters for asessment and treatment children and adolescent
with Tic disorders AACAP guidelines.
• 3.Tics and Tourette Syndrome ; Continuum on Movement Disorders, 2019.
• 4.The Clinical approach to movement disorders; Abdo .W. F et al;Nature
Neurology 2010.
• 5.Tourette Syndrome ;Roseli et al ; Psychiatric clinics of North America.
• 6.Practice guidelines: The treatment of tics in people with Tourette
Syndrome and Chronic Tic Disorder; AANP 2019
• 7.Clinical Asessment of Tourette Syndrome and Tic Disorder; Stephanie et al;
Neuroscience Behaviour Rev. 2013
• 8.Adult onset Tic disorder; Sylvian Chouinard; J Neurol Neurosurg Psychiatry.
• 9.Tics and Tourette Syndrome ; A handbook for Parents and Professionals;
Uttom Chowdhury
• 10. Tic Disorders: Neural Circuits, Neurochemistry,Neuroimmunology; Haris
et al , Jcn.sagepub.
Thank You

More Related Content

Similar to Tic Disorders ppt.pptx bshhsjsjsjsjjss jzjjjz

Abnormal body movement in children
Abnormal body movement in childrenAbnormal body movement in children
Abnormal body movement in childrenMaryamAbdulqadir
 
Neurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditionsNeurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditionsShünün G. Abrha
 
Tics 150729085345-lva1-app6891
Tics 150729085345-lva1-app6891Tics 150729085345-lva1-app6891
Tics 150729085345-lva1-app6891Cristian Broca
 
practical approach to movement disorders by M.Habeel.pdf
practical approach to movement disorders by M.Habeel.pdfpractical approach to movement disorders by M.Habeel.pdf
practical approach to movement disorders by M.Habeel.pdfMohamed Habeel
 
MOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptx
MOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptxMOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptx
MOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptxKrishnakumarBalarama1
 
Tic disorder DR MOHAMMAD ALKTIFAN
Tic disorder DR MOHAMMAD ALKTIFANTic disorder DR MOHAMMAD ALKTIFAN
Tic disorder DR MOHAMMAD ALKTIFANMohammad ALktifan
 
Neuropathies and Myopathies
Neuropathies and MyopathiesNeuropathies and Myopathies
Neuropathies and MyopathiesSCGH ED CME
 
Palsies & Neuralgias & Movement Disorders
Palsies & Neuralgias & Movement DisordersPalsies & Neuralgias & Movement Disorders
Palsies & Neuralgias & Movement DisordersPatrick Carter
 
Hyperkinetic Motor Disorders.pptx
Hyperkinetic Motor Disorders.pptxHyperkinetic Motor Disorders.pptx
Hyperkinetic Motor Disorders.pptxNaolShibiru
 
Childhood and juvenile movement disorders
Childhood  and juvenile movement disordersChildhood  and juvenile movement disorders
Childhood and juvenile movement disordersAmr Hassan
 

Similar to Tic Disorders ppt.pptx bshhsjsjsjsjjss jzjjjz (20)

Abnormal body movement in children
Abnormal body movement in childrenAbnormal body movement in children
Abnormal body movement in children
 
Tourettes Syndrome
Tourettes Syndrome Tourettes Syndrome
Tourettes Syndrome
 
Neurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditionsNeurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditions
 
tentatif Movdis.pptx
tentatif Movdis.pptxtentatif Movdis.pptx
tentatif Movdis.pptx
 
Tics
TicsTics
Tics
 
Tics 150729085345-lva1-app6891
Tics 150729085345-lva1-app6891Tics 150729085345-lva1-app6891
Tics 150729085345-lva1-app6891
 
practical approach to movement disorders by M.Habeel.pdf
practical approach to movement disorders by M.Habeel.pdfpractical approach to movement disorders by M.Habeel.pdf
practical approach to movement disorders by M.Habeel.pdf
 
MOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptx
MOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptxMOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptx
MOVEMENT DISORDER IN PAEDIATRICS 20.03.2019 sunjay.pptx
 
Tic disorder DR MOHAMMAD ALKTIFAN
Tic disorder DR MOHAMMAD ALKTIFANTic disorder DR MOHAMMAD ALKTIFAN
Tic disorder DR MOHAMMAD ALKTIFAN
 
Neuropathies and Myopathies
Neuropathies and MyopathiesNeuropathies and Myopathies
Neuropathies and Myopathies
 
Seizure Disorders
Seizure DisordersSeizure Disorders
Seizure Disorders
 
Multiple sclerosis 2015
Multiple sclerosis 2015 Multiple sclerosis 2015
Multiple sclerosis 2015
 
Dementia
DementiaDementia
Dementia
 
Movement disorders
Movement disordersMovement disorders
Movement disorders
 
Palsies & Neuralgias & Movement Disorders
Palsies & Neuralgias & Movement DisordersPalsies & Neuralgias & Movement Disorders
Palsies & Neuralgias & Movement Disorders
 
Movemet disorders
Movemet disordersMovemet disorders
Movemet disorders
 
Approach to dystonia
Approach to dystoniaApproach to dystonia
Approach to dystonia
 
Seizure disorders
Seizure disordersSeizure disorders
Seizure disorders
 
Hyperkinetic Motor Disorders.pptx
Hyperkinetic Motor Disorders.pptxHyperkinetic Motor Disorders.pptx
Hyperkinetic Motor Disorders.pptx
 
Childhood and juvenile movement disorders
Childhood  and juvenile movement disordersChildhood  and juvenile movement disorders
Childhood and juvenile movement disorders
 

More from ShanuSoni7

KMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx ggggggggggggggKMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx ggggggggggggggShanuSoni7
 
jenkuskyP101_MHC_BenzoForPharmacists_011617.ppt
jenkuskyP101_MHC_BenzoForPharmacists_011617.pptjenkuskyP101_MHC_BenzoForPharmacists_011617.ppt
jenkuskyP101_MHC_BenzoForPharmacists_011617.pptShanuSoni7
 
Dissociative Disorder final pk.pptx
Dissociative Disorder final pk.pptxDissociative Disorder final pk.pptx
Dissociative Disorder final pk.pptxShanuSoni7
 
Assessment of Personality Disorders.pptx
Assessment of Personality Disorders.pptxAssessment of Personality Disorders.pptx
Assessment of Personality Disorders.pptxShanuSoni7
 
Neurotrophic Factors Presentation.pptx
Neurotrophic Factors Presentation.pptxNeurotrophic Factors Presentation.pptx
Neurotrophic Factors Presentation.pptxShanuSoni7
 
OCD seminar Dr. Manish Singh-1.pptx
OCD seminar Dr. Manish Singh-1.pptxOCD seminar Dr. Manish Singh-1.pptx
OCD seminar Dr. Manish Singh-1.pptxShanuSoni7
 
GENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdfGENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdfShanuSoni7
 
THEORIES OF PERSONALITY(1).pptx
THEORIES OF PERSONALITY(1).pptxTHEORIES OF PERSONALITY(1).pptx
THEORIES OF PERSONALITY(1).pptxShanuSoni7
 
Theories of Personality.pptx
Theories of Personality.pptxTheories of Personality.pptx
Theories of Personality.pptxShanuSoni7
 

More from ShanuSoni7 (10)

KMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx ggggggggggggggKMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx gggggggggggggg
 
jenkuskyP101_MHC_BenzoForPharmacists_011617.ppt
jenkuskyP101_MHC_BenzoForPharmacists_011617.pptjenkuskyP101_MHC_BenzoForPharmacists_011617.ppt
jenkuskyP101_MHC_BenzoForPharmacists_011617.ppt
 
Dissociative Disorder final pk.pptx
Dissociative Disorder final pk.pptxDissociative Disorder final pk.pptx
Dissociative Disorder final pk.pptx
 
NMS.pptx
NMS.pptxNMS.pptx
NMS.pptx
 
Assessment of Personality Disorders.pptx
Assessment of Personality Disorders.pptxAssessment of Personality Disorders.pptx
Assessment of Personality Disorders.pptx
 
Neurotrophic Factors Presentation.pptx
Neurotrophic Factors Presentation.pptxNeurotrophic Factors Presentation.pptx
Neurotrophic Factors Presentation.pptx
 
OCD seminar Dr. Manish Singh-1.pptx
OCD seminar Dr. Manish Singh-1.pptxOCD seminar Dr. Manish Singh-1.pptx
OCD seminar Dr. Manish Singh-1.pptx
 
GENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdfGENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdf
 
THEORIES OF PERSONALITY(1).pptx
THEORIES OF PERSONALITY(1).pptxTHEORIES OF PERSONALITY(1).pptx
THEORIES OF PERSONALITY(1).pptx
 
Theories of Personality.pptx
Theories of Personality.pptxTheories of Personality.pptx
Theories of Personality.pptx
 

Recently uploaded

APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 

Recently uploaded (20)

Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 

Tic Disorders ppt.pptx bshhsjsjsjsjjss jzjjjz

  • 1. TIC DISORDERS Presenter: Dr. Sarah. N Chair: Dr. Tinku Wilson
  • 2. CONTENTS • Definition • History • Epidemiology • Etiopathogenesis • Classification • Clinical features • Diagnostic Criteria • Approach • DD &Comorbid conditions • Course and prognosis • Management
  • 3. INTRODUCTION • Tics: rapid, non rhythmic, recurring, involuntary or semi voluntary, sudden onset, motor movements or vocalizations. • Complex, heterogenous, neurodevelopmental disorders.
  • 4. HISTORY • Itard (1825) : first clinical description of Tourette syndrome on Marquise de Dampierre. • Georges Edouard Albert Brutus Gilles de la Tourette (1885) : described in 9 patients, coined term coprolalia • Charcot : believed in Heriditary degenerative disorder. Gilles de la Tourette
  • 5. EPIDEMIOLOGY Tic disorder overall prevalence 6.5% Typical age 3-8yrs Avg age 6yrs M>F by 3-4 times Provisional Tic D/o (MC) 20% prevalence in school age Persistent tic d/o 2-4% prevalence Tourette disorder 0.77% prevalence • 79% comorbid Mental health/ Neurodevelopment condition. • 60-70% comorbid ADHD • 50% comorbid OCD.
  • 6. ETIOPATHOGENESIS • CSTC • Androgen exposure • High hypothalamic- pituitary-adrenal axis • Prenatal and perinatal insults: • Hypoxia, ischaemia • Forceps delivery • Exposure to alcohol • Caffiene, cigarettes • Molecular Mimicry • Antineuronal antibodies. • PANDAS • Inherited Neurodevelop mental Disorder. GENETIC FACTORS IMMUNOLOGY NEUROPHYSIO AND NEUROCHEM ENVIRONMEN TAL
  • 7. Genetic factors • Twin studies: High concordance in MZ (50-90%) • Multigene loci with environmental factors. • Linkage study by TSAICG: linkage region on Chr 2p, duplication of long arm Chr 7 • Balanced transloction Chr 6 and 8 • Candidate gene SLITRK1 on Chr 13Q31.1 • Functional mutation of HDC encoding l-histidine decarboxylase. • Dopamine receptor gene, transporter gene, noradrenegic genes, serotonergic genes.
  • 9.
  • 10. Neurophysiology and Neurochemistry • : Dopaminergic abnormality Excessive cortical/ nigrostriatal dopaminergic activity. Dopamine tonic-phasic model Serotonergic abnormality Decreased Serotonin in BG and CSF Influence Dopamine release Norepinephrine Increase: Influence Dopamine surge
  • 11. fMRI: Voluntary tic supression : activity in DLPFC, CN SPECT :Abnormal Dopaminergic Neurotransmission. Midbrain dopaminergic neurons. MRS : Neurochemichal changes • Loss of assymmetry of BG • Volumetric changes in Striatum, thalamus, amygdala, hippocampus • PFC & CN volume changes: inversely related to tic • Corpus callosal volume changes • Cortical thinning: Frontal and Parietal lobes. Neuroimaging
  • 12.
  • 13. CLASSIFICATION PRIMARY Sporadic a. Transient tic d/o b. Chronic tic d/o c. Adult onset tics d. TS Inherited a. TS SECONDARY 1. Inherited: Huntington, Neuroacanthocytosis, TS, WD, Duchene Mascular Dystrophy 2. Infections: CJD, Neurosyphilis, Sydenham 3. Drugs:Antipsychotics, Levodopa, Amphetamine, Methylphenidate 4. Toxins: CO 5. Chromosomal Disorders: ASD 6. Developmental: Downs, XXY, Fragile X 7. Others: Trauma, Stroke, Neurodegenerative d/s
  • 14. TICS MOTOR • Simple • Clonic:eye blinking, shoulder shrugging, head turning • Dystonic: blepharospsm, bruxism, torticollis, occcular deviation, mouth opening. • Tonic : tensed abdominal or limb muscles. • Complex: touching, jumping, rotating, echopraxia, copropraxia VOCAL • Simple: throat clearing, coughing, sniffing, blowing, barking • Complex: palilalia, echolalia, coprolalia
  • 15. CLINICAL FEATURES • Occurs in bouts. • Change in frequency, anatomical site, number, complexity, severity. • May persist during sleep • Can be suppressed. • Associated with sensory phenomenon.
  • 16. • Premonitary urges: uncomfortable sensation preceding tics, need to itch, sneeze, restlessness…Mounting tension. • 82-92% of adults and adolescent reports PU. • warning sign : can be utilized in CBT. • Execution of a tic till it feels good : “Just right phenomenon” • Somatic hypersensitivity: deficit in sensorimotor gating in TS and Schizophrenia. • Prepulse inhibition: startle response to low intensity stimulus prevents startle response to high intensity stimulus of same kind; impaired in TS.
  • 17. Exacerbating and relieving factors. Exacerbating • Tic related conversation. • Overt observation • Stress • Anxiety • Public commenting Relieving • Relaxation • Mental or Physical task • Rewarding tic free period.
  • 18. PANDAS • Paediatric Autoimmune Neuropsychiatric Disorder Associated with Stretococcus • Gp A betahaemolytic streptococci. • Molecular mimicry • Multiple streptococcal infection in preceding 12 months : high risk. • Evaluation of Tic/ OCD for pharyngitis/ Strep exposure; throat culture, ASO, anti-DNAse B titres. • Antibiotics Diagnostic Features • OCD & tic symptom • Pre pubertal onset • Episodic course • Sudden explosive onset • Exacerbation and remissions • Temporal relation with GABHS infection.
  • 19. Diagnostic Criteria • DSM 5 Neurodevelopmental disorders • Tourette Disorder: Both multiple motor and vocal tics >1 yr since first tic onset Onset before 18yrs • Persistent (Chronic) Motor or Vocal Tic Disorder Single or multiple motor or vocal tic, not both. • Provisional Tic disorder Motor and/or vocal tics <1 yr since onset. • Other specified & Unspecified Tic Disorders. • ICD 10 Disorders of Childhood and Adolesence F95 Tic disorders • F95.0 Transient Tic Disorder : <12 months • F95.1 Chronic Motor or Vocal Tic Disorder. • F 95.2 Combined vocal and multiple motor tic disorder (de la Tourette’s syndrome) • Other tic disorders( F95.8) and unspecified(F95.9)
  • 20. ICD 11 • Chapter 8 : Diseases of Nervous System • Primary & Secondary
  • 21. Adult onset tic disorder • True Prevalance not known • ~55% recurrence of childhood tic disorder • Of New adult onset tics, 50% has precipitating factors. • Often involve face, neck and shoulders. • Inciting event: head injury, local infection, cocaine binge, neuroleptic drugs. • Many unaware, unnoticed tics in childhood and family members. • Comorbid OC symptoms.
  • 22. Approach to Tic disorders. 1. History : • Present illness: Onset, course, severity, pattern, burden on emotional, social, family, academic function ,ability to supress, premonitory urges, aggrevating/ allevating factors, comorbidities, medications/ substances. • Developmental history, medical history. • All child cases should be screened for unusual movements/ vocalizations. 2. Physical examination( including neurology) Ht, Wt, dysmorphic features, posture, gait, reflex. • AIMS • Videotaped interviews
  • 23. • Investigations: to r/o infectious etiology, Huntington disease, Wilson disease. • Specific neurological finding : Neuroimaging, genetic workup, EEG. Categorisation : types, dominant one, associated features, DDs Sudden onset ,severe tics, atypical tics, mental status abnormalities : organic process : detailed investigation.
  • 24. Rating Scales Yales Global Tic Severity Scale (YGTSS): assess number, frequency, complexity, intensity, interference of vocal and motor tics. (Clinician rated) Tic Symptom Self Report Tourette Syndrome Diagnostic confidence index (TSDCI) Shapiro TS Severity Scale TS Symptom list(TSSL) Motor tic, Obsession and compulsion, vocal tic evaluation survey (MOVES) Clinical Global Impression Scale
  • 25. Differential Diagnosis TICS Abnormal movements Myoclonus Tremors Akathesia Athetosis Chorea Dystonia Stereotypy Spasm Ballismus Dyskinesia Obsessive Compulsive Disorder Huntington Disease Sydenham’s Chorea Hallevorden-Spatz Wilson disease Neuroacanthocytos is Substance induced Neuroleptic induced Post traumatic CO Poisoning Developmental and benign movement disorders
  • 26. Comorbid conditions OCD Impulse control Disorders : Self Injurious behaviour, Intermittent explosive diorder Learning disorder (22.7%) Mood disorder ADHD
  • 27. ADHD AND TICS 50-75% have ADHD 10/-30% OF ADHD have tics Low frustration tolerance, over aggression, Self injurious behaviour Poor treatment adherence Inability to delay gratification. Academic difficulty Peer rejection Poor outcome
  • 28. OCD AND TICS 20-40 % meet criteria for OCD Differ in subjective experience of Cognition, Anxiety and Sensory phenomen on. 90% subthreshold symptoms: repetitive counting, touching, symmetry. Share similar Neurobiology: overlap of symptoms. More severe tics, depressive anxiety symptoms Comorbid Trichotillomania, BDD,Social Phobia
  • 29. Course and Prognosis 6-7 yrs • Motor tics • Rostrocaudal progression • 94.8% eye tics 8-9 yrs • Vocal tics • Simple to complex 11-12 yrs • OC symptoms •Waxing-waning course •Improve mid adolesence to adulthood; 65% •19.3% coprophenomenon. Course of Tourette Syndrome
  • 30. Prognostic factors Comorbidities OCD and ADHD Presence of Copropheno menon and Severe tics Poor Parent child interaction Peer difficulties and Traumatic life events
  • 31. Management • Physical pain • Impaired social/academic/occupati onal performance. Indication • Decrease symptoms • Support adaptive functioning and strength • Enhance developmental progress. Treatment goals
  • 32.
  • 33. Psychoeducation Parent-Teachers-Physician work as partners. Discuss family’s concerns and questions. Optimal school environment. Continuing education and support: Tourette Syndrome Association.
  • 34. Behavioural Interventions • First line treatment : Cognitive Behavioural Intervention • Habit Reversal Training (HRT) forms essence of Comprehensive Behavioural Intervention for Tics (CBIT) • Exposure and Response Prevention. Competing response training Relaxation training Awareness training Contingency management Social support and relapse prevention
  • 35. At Home Argumentati ve :123 technique time out Coprolalia: more acceptable words Reward acceptable behaviour Address Sibling concerns. Me time” for caretaker Screen time; sleep hygiene. Addressing public comments Responsible behaviour After school bursts: Relaxation techniques, sport activities Be consistent, clear & specific
  • 36. At School • Parent-Teacher communication • Avoiding , Critical /Negetive comments • Rewarding good behaviour: Token system; Good behaviour Diary • Proper seating arrangements; permission to leave classroom. • Breaking activities to small chunks; using visual cues • Extra time at exam/ worksheet with minimum writing requirement. • Public performance :not compelling • Address peer bullying • Building Self esteem
  • 37. Medications • Individualised planning: Addressing Comorbidities (OCD, ADHD, Mood disorders) • Initial work up: Blood parameters; ECG;FLP • Lowest dose; gradual titration • Monotherapy Indication Moderate-severe tics/ interfering all functional areas Psychotherapeutic options unavailable/ not beneficial
  • 38. Antipsychotics • FDA approved : Haloperidol, Pimozide. • Typicals: MOA: Block postsynaptic D2 receptors in BG. • A/E : EPS • Haloperidol: Children :0.125-0.25 mg daily Adults :0.5 mg/day • Pimozide :Children 0.5-1 mg; adults 1 mg/day QT prolongation (CCB)
  • 39. • Atypicals: Risperidone (most effective), Olanzapine, Ziprasidone, Aripiprazole. • MOA: block D2 & 5HT2 receptors • Risperidone :1-3 mg, started at 0.25-0.5mg • Ziprasidone 20-80mg, started at 5-10 mg • Aripiprazole : 2.5-15mg ; started at 1.25-2.5mg A/E: wt gain(Olanzapine), QT prolongation (Ziprasidone), Akathesia, sedation (Aripiprazole)
  • 40. Alpha adrenergic agonists • First line ; comorbid ADHD Clonidine α2 agonist: presynaptic autoreceptors at Locus Ceruleus Prepubertal: 0.025mg Adult :0.05mg By 0.025 mg every 5-14 days 0.05mg increments upto 8 μg /kg/day Head ache, dry mouth, stomach ache, sedation, mid sleep awakening, irritability. Guanfacine Postsynaptic prefrontal α adrenergic receptors Prepubertal :0.25mg Adult 0.5 mg By 0.025 mg every 5-14 days 0.05mg increments upto 3 mg/day Sedation, mid sleep wakening, constipation, hypotension. •Transdermal form, Long acting Oral form available •Monitor : ECG, BP, PR
  • 41. Others • SSRI: Tics + OC Fluoxetine : Adults 20-80 mg; Children : 10-20mg • TCA : Clomipramine, Desipramine • Benzodiazepines: Anxiolytic • Stimulants : Tic+ ADHD :Methylphenidate (0.1-0.5mg/kg) • Non stimulant: Atomexitine • Naltrexone(Opoid antagonist) :Self injurious behaviour.
  • 43. • Surgical Interventions: DBS, TMS • DBS: Severe, treatment resistant, Self injurious tics/cervical tics Regions stimulated: Centromedian Nucleus of Thalamus, Gp interna , Gp externa, STN, ventral striatum, NA. Botulinum Toxin Inj : Onabotulinum Toxin A For vocal tics Last 12-16 weeks Hypophonia
  • 44. CONCLUSION • Tics are Neurodevelopmental Disorders with Multiple Etiopathogenesis. • Classified as Motor and Vocal, Categorized again on severity basis. • Clinical features; Premonitary Urges, Sensory phenomenon distinguishing features. • Most common comorbid conditions are ADHD and OCD. • Approach and evaluation to arrive at a diagnosis. • Most require only Psychoeducation. First line management: Behavioural Interventions. • Medication only in selected cases, Individualized approach.
  • 45. REFERENCE • 1. Kaplan and Sadock Comprehensive Text Book of Psychiatry 10th edition. • 2.Practice parameters for asessment and treatment children and adolescent with Tic disorders AACAP guidelines. • 3.Tics and Tourette Syndrome ; Continuum on Movement Disorders, 2019. • 4.The Clinical approach to movement disorders; Abdo .W. F et al;Nature Neurology 2010. • 5.Tourette Syndrome ;Roseli et al ; Psychiatric clinics of North America. • 6.Practice guidelines: The treatment of tics in people with Tourette Syndrome and Chronic Tic Disorder; AANP 2019 • 7.Clinical Asessment of Tourette Syndrome and Tic Disorder; Stephanie et al; Neuroscience Behaviour Rev. 2013 • 8.Adult onset Tic disorder; Sylvian Chouinard; J Neurol Neurosurg Psychiatry. • 9.Tics and Tourette Syndrome ; A handbook for Parents and Professionals; Uttom Chowdhury • 10. Tic Disorders: Neural Circuits, Neurochemistry,Neuroimmunology; Haris et al , Jcn.sagepub.
  • 46.

Editor's Notes

  1. Parkinson disease